Horrell Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50
| Closed | -$1K | – | 237 |
|
|
2024
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 227 |
|
|
2023
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 219 |
|
|
2023
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 213 |
|
|
2023
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 211 |
|
|
2023
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 208 |
|
|
2022
Q4 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 207 |
|
|
2018
Q1 | – | Sell |
-64
| Closed | -$1K | – | 184 |
|
|
2017
Q4 | $1K | Hold |
64
| – | – | ﹤0.01% | 175 |
|
|
2017
Q3 | $1K | Hold |
64
| – | – | ﹤0.01% | 172 |
|
|
2017
Q2 | $1K | Hold |
64
| – | – | ﹤0.01% | 167 |
|
|
2017
Q1 | $2K | Hold |
64
| – | – | ﹤0.01% | 166 |
|
|
2016
Q4 | $2K | Hold |
64
| – | – | ﹤0.01% | 165 |
|
|
2016
Q3 | $3K | Hold |
64
| – | – | ﹤0.01% | 159 |
|
|
2016
Q2 | $3K | Buy |
+64
| New | +$3K | ﹤0.01% | 172 |
|